Peter Reimer
Impact in
-
- Lymphoma Diagnosis and Treatment
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
Papers in
-
- Lymphoma Diagnosis and Treatment 27
- Hematology 20
- Multiple Myeloma Research and Treatments 11
- Acute Myeloid Leukemia Research 7
- Hematopoietic Stem Cell Transplantation 4
- Co-authors
- Florian Weißinger (10 shared papers)Volker Kunzmann (6 shared papers)Martin Wilhelm (10 shared papers)Thomas Rüdiger (11 shared papers)Thomas M. Ruediger (5 shared papers)Hans‐Peter Tony (1 shared paper)Susanne Eckstein (1 shared paper)Eva Geissinger (11 shared papers)
- Journals
- Blood (8 papers)Journal of Clinical Oncology (6 papers)Leukemia (3 papers)Annals of Hematology (3 papers)European Journal Of Haematology (2 papers)
- Partner nations
- GermanyHungaryUnited States
In The Last Decade
Peter Reimer
51 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 66
- Pathology and Forensic Medicine 1.1k
- Hematology 763
- Immunology 390
- Oncology 391
- Dermatology 61
Countries citing papers authored by Peter Reimer
This map shows the geographic impact of Peter Reimer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Reimer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Reimer more than expected).
Fields of papers citing papers by Peter Reimer
This network shows the impact of papers produced by Peter Reimer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Reimer. The network helps show where Peter Reimer may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Reimer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 54 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 491 | |
| 2 | 2008 | 344 | |
| 3 | 2018 | 198 | |
| 4 | 2003 | 142 | |
| 5 | 2007 | 138 | |
| 6 | 2003 | 128 | |
| 7 | 2007 | 124 | |
| 8 | 2010 | 122 | |
| 9 | 2017 | 118 | |
| 10 | 2016 | 63 | |
| 11 | 2004 | 59 | |
| 12 | 2020 | 58 | |
| 13 | 2022 | 58 | |
| 14 | 2010 | 50 | |
| 15 | 2004 | 46 | |
| 16 | 2020 | 44 | |
| 17 | 2024 | 41 | |
| 18 | 2017 | 30 | |
| 19 | 2010 | 29 | |
| 20 | Allogeneic or autologous transplantation as first-line therapy for younger patients with peripheral T-cell lymphoma: Results of the interim analysis of the AATT trial. | 2015 | 25 |
About Peter Reimer
Peter Reimer is a scholar working on Pathology and Forensic Medicine, Hematology, Oncology, Biotechnology and Dermatology, having authored 54 papers that have together received 2.6k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (27 papers), Multiple Myeloma Research and Treatments (11 papers), Acute Myeloid Leukemia Research (7 papers), Hematopoietic Stem Cell Transplantation (4 papers), Colorectal Cancer Treatments and Studies (2 papers), COVID-19 Clinical Research Studies (1 paper), Helicobacter pylori-related gastroenterology studies (1 paper) and T-cell and B-cell Immunology (1 paper). The work is most often cited by research in Pathology and Forensic Medicine (1.1k citations), Hematology (763 citations), Immunology (390 citations), Oncology (391 citations) and Dermatology (61 citations). Peter Reimer has collaborated with scholars based in Germany, Hungary and United States. Frequent co-authors include Florian Weißinger, Volker Kunzmann, Martin Wilhelm, Thomas Rüdiger, Thomas M. Ruediger, Hans‐Peter Tony, Susanne Eckstein, Eva Geissinger, Hans Konrad Müller‐Hermelink and Norbert Schmitz. Their work appears in journals such as Blood, Journal of Clinical Oncology, Leukemia, Annals of Hematology and European Journal Of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.